A new nitrosourea derivative for the treatment of chronic myelogenous leukemia.
Hiraoka A, Masaoka T, Shibata H, Miyazaki T, Nakamura T, Yasunaga K, Kitani T, Yonezawa T, Kawagoe H, Horiuchi A, et al.
Hiraoka A, et al. Among authors: yasunaga k.
Leuk Res. 1988;12(6):487-90. doi: 10.1016/0145-2126(88)90115-4.
Leuk Res. 1988.
PMID: 3043111
Clinical Trial.